Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
April 1, 2015
An Epilepsy Drug to Prevent Cognitive Decline?
An atypical antiepilepsy drug is being investigated for a possible role in treating patients with mild cognitive impairment (MCI).
A new study shows that low doses of levetiracetam reduced the overactivation in subregions of the hippocampus that have been linked to amnestic MCI (aMCI) — the dentate gyrus (DG) and the cornu ammonis 3 (CA3) — and improved memory in patients with cognitive impairment.
